Soluble Scavenger Receptor B2 (SCAB2) Trap is an Antiviral Agent for Hand,  Foot,  and Mouth Disease Viruses

Ha-Eun Jeon; Hong-Gi Kim; Ji-Wha Shin; Byung-Kwan Lim

doi:10.4167/jbv.2025.55.3.248

All Issue

2025 Vol.55, Issue 3 Preview Page Next Page

Original Article

Soluble Scavenger Receptor B2 (SCAB2) Trap is an Antiviral Agent for Hand, Foot, and Mouth Disease Viruses

30 September 2025. pp. 248-257

PDF XML

Abstract

Hand, foot, and mouth disease (HFMD) can show severe clinical symptoms in children and infants, such as fever, mouth ulcers, and vesicular rashes on the palms and feet. Enterovirus 71 (EV71) is the leading cause of this disease. In this study, we investigated the antiviral effect of soluble scavenger receptor type B2 (SCAB2, CD36) to develop a new therapeutic approach for HFMD. Soluble SCAB2: Fc was generated by using the human IgG1 Fc region. The SCAB2 gene was cloned into the expression plasmid with human IgG1 Fc sequences (SCAB2:Fc/PCK). SCAB2:Fc/PCK plasmid was transfected into HEK293T cells for 72 hours. Then the cell protein was extracted, and the culture supernatant was collected. The supernatant SCAB2:Fc protein was concentrated, and its concentration was measured using a human IgG1 ELISA kit. SCAB2:Fc strongly blocked the EV71 target cell entry in a dose-dependent manner. The antiviral activity of SCAB2:Fc was observed by western blot analysis and reverse transcription PCR (RT-PCR). VP1 capsid protein and virus-positive-strand RNA were significantly decreased in 100 ng/ml of SCAB2:Fc treatment. Transcription factor, eIF4G1, and cleaved caspases3 levels were reduced considerably with SCAB2:Fc treatment. Moreover, inhibiting virus infection strongly suppressed virus replication and cell proliferation regulating MAPK signaling. The phosphorylation of p38 and ERK1/2 was significantly decreased by SCAB2:Fc treatment. These data suggested that SCAB2:Fc inhibited EV71 infection and virus replication-induced MAPK signaling activity. In this study, the antiviral effect of soluble SCAB2 was investigated to develop an EV71 treatment. Soluble SCAB2:Fc showed potent antiviral activity in vitro, and it could be a potential candidate material to use as a therapeutic drug for EV71- induced HFMD.

Keywords

Enterovirus 71

Scavenger receptor type B2

Soluble receptor

Antiviral drug

HFMD

References

Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science. 2012;336(6086):1274.

10.1126/science.121871322383808PMC3448362

Kim SH, Lee J, Jung YL, Hong A, Nam SJ, Lim BK. Salvianolic Acid B Inhibits Hand-Foot-Mouth Disease Enterovirus 71 Replication through Enhancement of AKT Signaling Pathway. J Microbiol Biotechnol. 2020;30(1):38-43.

10.4014/jmb.1907.0707931752055PMC9728356

McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26(1):91-107.

10.1111/j.1574-6976.2002.tb00601.x

Chen Z, Sun H, Yan Y, Wang Y, Zhu C, Zhou W, et al. Epidemiological profiles of hand, foot, and mouth disease, including meteorological factors, in Suzhou, China. Arch Virol. 2015;160(1):315-321.

10.1007/s00705-014-2294-x

Chen TC, Weng KF, Chang SC, Lin JY, Huang PN, Shih SR. Development of antiviral agents for enteroviruses. J Antimicrob Chemother. 2008;62(6):1169-1173.

10.1093/jac/dkn424

Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778-790.

10.1016/S1473-3099(10)70194-8

Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097-0105.

10.1016/S1474-4422(10)70209-X

Tan CW, Lai JK, Sam IC, Chan YF. Recent developments in antiviral agents against enterovirus 71 infection. J Biomed Sci. 2014;21(1):14.

10.1186/1423-0127-21-1424521134PMC3924904

Yamayoshi S, Fujii K, Koike S. Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Front Microbiol. 2012;3:32.

10.3389/fmicb.2012.0003222363322PMC3277273

Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012;86(10):5686-5696.

10.1128/JVI.00020-1222438546PMC3347270

Hsiao HB, Chou AH, Lin SI, Lien SP, Liu CC, Chong P, et al. Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice. Biomed Res Int. 2014;2014:878139.

10.1155/2014/87813925243194PMC4163470

Liou AT, Wu SY, Liao CC, Chang YS, Chang CS, Shih C. A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71. Sci Rep. 2016;6:31151.

10.1038/srep3115127499235PMC4976353

Lim BK, Choi JH, Nam JH, Gil CO, Shin JO, Yun SH, et al. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc Res. 2006;71(3):517-26.

10.1016/j.cardiores.2006.05.016

Lim BK, Xiong D, Dorner A, Youn TJ, Yung A, Liu TI, et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J Clin Invest. 2008;118(8):2758-2770.

10.1172/JCI3477718636119PMC2467382

Lee KH, Kim KW, Rhee KH. Identification of Streptomyces sp. KH29, which produces an antibiotic substance processing an inhibitory activity against multidrug-resistant Acinetobacter baumannii. J Microbiol Biotechnol. 2010;20(12):1672-1676.

Esfandiarei M, Luo H, Yanagawa B, Suarez A, Dabiri D, Zhang J, et al. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J Virol. 2004;78(8):4289-4298.

10.1128/JVI.78.8.4289-4298.200415047842PMC374262

Li X, Li Z, Zhou W, Xing X, Huang L, Tian L, et al. Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells. Cell Death Dis. 2013;4(9):e803-809.

10.1038/cddis.2013.33124030155PMC3789189

Kim SH, Shin HH, Kim JH, Park JH, Jeon ES, Lim BK. Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis. Int J Mol Sci. 2022;23(3):1489.

10.3390/ijms2303148935163412PMC8836114

Zhang Z, Wang B, Wu S, Wen Y, Wang X, Song X, et al. PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71. Virology. 2017;508:150-158.

10.1016/j.virol.2017.05.012

Lim BK, Kim JH. ORI2 inhibits coxsackievirus replication and myocardial inflammation in experimental murine myocarditis. Biol Pharm bull. 2014;37(10):1650-1654.

10.1248/bpb.b14-00408

Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, et al. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest. 2002;109(12):1561-1569.

10.1172/JCI200213971

Wong WR, Chen YY, Yang SM, Chen YL, Horng JT. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 2005;78(1):82-90.

10.1016/j.lfs.2005.04.07616150462PMC7094582

Information

Publisher :The Korean Society for Microbiology and The Korean Society of Virology
Publisher(Ko) :대한미생물학회‧대한바이러스학회
Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
Volume : 55
No :3
Pages :248-257
Received Date : 2025-06-17
Revised Date : 2025-09-25
Accepted Date : 2025-09-25
DOI :https://doi.org/10.4167/jbv.2025.55.3.248

JOURNAL OF BACTERIOLOGY AND VIROLOGY ISSN:1598-2467(Print) 2093-0429(Online)

All Issue